1999年～2002年6城市医院抗肿瘤药物用药变化及趋势分析  

Changes of the Usage of Antitumor Drugs and Analysis of the Tendency in the Hospitals of 6 Cities During 1999-2002

作　　者：黄萍[1] 陈庆宪[1] 

机构地区：[1]重庆医科大学附属第一医院,重庆市400016

出　　处：《中国医院用药评价与分析》2004年第1期23-26,共4页Evaluation and Analysis of Drug-use in Hospitals of China

摘　　要：目的分析6城市150家医院抗肿瘤药物用药的现状和趋势。方法:统计6城市150家医院抗肿瘤药物用药的金额、生产企业等,分析临床用药情况。结果:抗肿瘤用药金额2002年比1999年、2000年和2001年分别增加118.85％、74.40％和32.15％。结论:抗肿瘤药物在医院占有重要地位,且逐年快速增长(年均增长率为29.80％),抗肿瘤植物药、单抗药物和基因疗法将成为今后抗肿瘤药物治疗的主要趋势。OBJECTIVE: To analyze the current status and the tendency for using antitumor drugs in 150 hospitals of 6 cities. METHODS: By counting sum of money of antitumor drugs and manufacturers in 150 hospitals of 6 cities, to analyze the status of clinical drug usage. RESULTS: Sum of money of antitumor drugs in 2002 respectively increased by 118.85%, 74.4% and 32.15% than that in 1999, 2000 and 2001. CONCLUSION: Antitumor drugs play an important part in the hospitals and increase quickly with years (the average annual incremental rate is 29.80%). Antitumor plant amedica, simple antitumor drugs and gene therapy will become main tendency for antitumor drug therapy in the future.

关 键 词：1999年-2002年 医院 抗肿瘤药物 用药变化 癌症 

分 类 号：R979.1[医药卫生—药品]